Regulatory Peptides 1998-10-16

Regulation of the renal Na-HCO3 cotransporter: IX. Modulation by insulin, epidermal growth factor and carbachol.

O S Ruiz, Y Y Qiu, L R Cardoso, J A Arruda

Index: Regul. Pept. 77(1-3) , 155-61, (1998)

Full Text: HTML

Abstract

To examine the role of tyrosine kinase (TK) on basolateral membrane (BLM) transport, we looked for the presence of TK activity in these membranes and showed that the synthetic substrate for TK, poly [Glu80 Na, Tyr20] caused a three-fold increase in tyrosine phosphorylation. This effect was completely blocked by the TK inhibitors, 2-hydroxy-5(2,5-dihydroxybenzyl) aminobenzoic acid (HAC), 1 microM, and methyl 2,5-dihydroxycinnamate (DHC), 5 microM. We then examined the effect of agents that cause TK stimulation on tyrosine kinase immunocontent and on the Na-HCO3 cotransporter activity in BLM and in primary cultures of the proximal tubule. We utilized the cholinergic agent, carbachol (10(-4) M), epidermal growth factor (EGF 10(-8) M), and insulin (10(-8) M), well known activators of TK. Carbachol, insulin, and EGF caused a significant increase in TK immunoreactive protein content which was blocked by HAC and DHC. In BLM, carbachol significantly stimulated HCO3-dependent 22Na uptake and this effect was totally prevented by the monoclonal antibody against TK. In cultured proximal tubule cells, carbachol, EGF and insulin at physiologic concentration caused a significant stimulation of the cotransporter activity and this effect was completely blocked by the TK inhibitor, HAC. Increasing the dose of insulin 100-fold did not cause further stimulation of the cotransporter indicating that insulin plays a permissive role on the cotransporter. These results demonstrate the presence of TK in renal proximal tubule cells and show that activation of this kinase by dissimilar agents enhance the activity of the Na-HCO3 cotransporter.


Related Compounds

  • Methyl (2E)-3-(2,...

Related Articles:

Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors.

2001-01-23

[Biochemistry 40(3) , 777-90, (2001)]

Mechanism of topoisomerase II inhibition by staurosporine and other protein kinase inhibitors.

1996-10-18

[J. Biol. Chem. 271(42) , 26418-23, (1996)]

Signal pathways that transduce growth factor-stimulated mitogenesis in bone cells.

1998-07-01

[Bone 23(1) , 17-26, (1998)]

Suppression of tyrosine kinase activity inhibits [3H]thymidine uptake in cultured human pituitary tumor cells.

1997-07-01

[J. Clin. Endocrinol. Metab. 82(7) , 2143-7, (1997)]

Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells.

2007-08-01

[Exp. Cell Res. 313(13) , 2753-65, (2007)]

More Articles...